Advanced and Metastatic Cancer
Advanced and metastatic cancer refers to cancer that has spread from its original site to other parts of the body, often making treatment more complex.
Endometrial Cancer: New Treatment Combination
We are studying a new combination of a dual mTOR inhibitor and anastrozole for women with metastatic hormone receptor-positive endometrial cancer. The goal is to see if this combination works better than anastrozole alone.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Institut De Cancerologie De L Ouest
Medical Oncology
Avignon, France
Institut Bergonie
Medical Oncology
Bordeaux, France
Centre Oscar Lambret
Medical Oncology
Loos, France
Sponsor: Centre Leon Berard
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.